LinkedInXFacebook
Subscribe
Orthopedics This Week
  • Opinions
  • |My Feed
  • |Events
  • |Company Directory
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
Company News

ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT

October 13, 2026 3 min read Premium comments

Advertisement

ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT
Courtesy of Zimmer Biomet and THINK Surgical
Zimmer Biometdistribution agreementTHINK SurgicalPersona Knee SystemexclusiveTMINI Miniature Robotic Syste

FREMONT, Calif. and WARSAW, Ind., Oct. 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced a multi-year extension of its Limited Exclusive Distribution and Supply Agreement following a successful partnership during the initial term of the agreement. 

Under the extension, Zimmer Biomet will continue to distribute an exclusive version of THINK's wireless, handheld TMINI Miniature Robotic System over a multi-year period. This exclusive version of the TMINI System is compatible with Zimmer Biomet's Persona Knee System.

"This extension confirms the value the TMINI System has been providing to Zimmer Biomet's customers and their patients," said THINK Surgical CEO Stuart Simpson. "We look forward to continuing to work with the Zimmer Biomet team to accelerate adoption of the TMINI System."

Brad Kessler, President, Americas – Robotics, Technology and Data for Zimmer Biomet, said, "THINK Surgical's TMINI System addresses the needs of our customers who want a wireless, handheld robotic system for use with the Persona Knee System. THINK has been a valuable partner to us as we drive our strategy to offer the broadest and most flexible ecosystem of robotics and enabling technologies to meet the diverse preferences of a vast array of orthopedic surgeons. We look forward to continuing the relationship and supporting the TMINI System with the same commitment we bring to our own technologies as we expand access for surgeons and patients across the US."

For more information on TMINI, visit thinksurgical.com/tmini

About THINK Surgical, Inc. 

THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon. Through its Limited Exclusive Distribution and Supply Agreement with Zimmer Biomet, THINK Surgical also offers an exclusive, customized TMINI robotic solution integrating Zimmer Biomet technology for total knee arthroplasty.

THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology. Please refer to the instructions for use for the TMINI® Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com.

THINK Surgical and TMINI are registered trademarks of THINK Surgical, Inc.

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

Advertisement

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet's periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC.

*Please check for country product clearance and reference product-specific instructions for use. Statements regarding the future direction of orthopedic robotics are forward-looking and do not describe any product that is currently available for sale; nothing herein should be construed as a promotion of an unapproved product or indication.

THINK Surgical Contact:

Media
Jonathan Gibson
jgibson@thinksurgical.com

Contacts:

 

Media

Troy Kirkpatrick

614-284-1926

et.com

troy.kirkpatrick@zimmerbiom

 

Ben Freeland

716-461-4341

ben.freeland@zimmerbiomet.com 

Investors

David DeMartino

646-531-6115

david.demartino@zimmerbiomet.com

 

Zach Weiner

908-591-6955

zach.weiner@zimmerbiomet.com 

SOURCE Zimmer Biomet Holdings, Inc.

Author

TH
TJ Halvorson

The De Angelis Group | Orthopedics This Week | MSK Innovations

Why This Matters

Two Perspectives

MBA Lens: Economic and industry impact

Zimmer Biomet extended its exclusive multi-year distribution agreement with THINK Surgical for the TMINI Miniature Robotic System, compatible with Zimmer Biomet's Persona Knee System. This strategic move aims to accelerate adoption of a wireless, handheld robotic solution, enhancing Zimmer Biomet's competitive position by offering a broader, more flexible robotics ecosystem to meet diverse surgeon preferences and expand market access.

  • The extension reinforces Zimmer Biomet's strategy to provide a comprehensive suite of robotic and enabling technologies.
  • This partnership strengthens Zimmer Biomet's offering in the competitive orthopedic robotics market, leveraging THINK Surgical's innovative TMINI system.

PhD Lens: Clinical and outcomes impact

Zimmer Biomet and THINK Surgical extended their agreement for the TMINI Miniature Robotic System, a wireless, handheld device designed for total knee arthroplasty. The TMINI System is exclusively compatible with Zimmer Biomet's Persona Knee System, providing surgeons with a precise, accurate, and intelligent technology. The extension follows a successful initial partnership, indicating perceived clinical value for customers and patients.

  • The TMINI system is a wireless, handheld robotic solution for total knee arthroplasty, integrating with Zimmer Biomet's Persona Knee.
  • The agreement's extension suggests positive feedback and perceived clinical utility from the initial term, supporting continued adoption.
React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

Orthopedics This Week’s mission is to connect the orthopedic community with the people, ideas, and innovations shaping the future of musculoskeletal care.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Opinions
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, opinions, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy